University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
Location contact
Benjamin Abella, MD, MPhil
PRINCIPAL_INVESTIGATOR
Eileen McDonnell
CONTACT
Felipe Teran, MD, MSCE
SUB_INVESTIGATOR
NCT Number: NCT04972526
The general objective of this study is to evaluate the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) used during the evaluation of critically-ill patients in the emergency and intensive care settings. The target population for this study are critically-ill patients over the age of 18 who as part of their routine clinical care are receiving a focused TEE.
The primary objective of this study is to determine the clinical impact and safety of TEE performed during the evaluation of critically-ill patients in the emergency department and intensive care settings.
The secondary objective(s) of this study are to characterize the use of this imaging modality in the subsets of critically-ill patients in shock and cardiac arrest; including but not limited to; description of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
Benjamin Abella, MD, MPhil
PRINCIPAL_INVESTIGATOR
Eileen McDonnell
CONTACT
Felipe Teran, MD, MSCE
SUB_INVESTIGATOR
Vision
The Resuscitative TEE Collaborative Registry aims to accelerate the development of outcome-oriented research and knowledge translation on the use of TEE in emergency and critical care settings.
Mission
The registry aims to catalyze clinical research involving the use of TEE in critically-ill patients through the following strategic initiatives:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From the time of admission to the hospital until the date of discharge from the hospital or date of death from any cause, whichever occurs first, assessed up to 12 weeks
Determination of ROSC and survival to hospital discharge
Time frame: From the time of admission to the hospital until the date of discharge from the hospital or date of death from any cause, whichever occurs first, assessed up to 12 weeks
Description of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.
Contact information is provided by the study sponsor or research team.
Caleb Suh
CONTACT
Felipe Teran, MD, MSCE
CONTACT
University of Pennsylvania
Other
Evaluation of the Clinical Impact and Safety of Focused Transesophageal Echocardiography During Resuscitation of Critically Ill Patients in the Emergency Department and Intensive Care Settings
Acronym: rTEECoRe
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00780299
Cardiac Arrest, Cardiovascular Diseases
Paris, France
View Trial DetailsNCT04791995
Cardiac Arrest, Cardiac Arrest, Out-Of-Hospital
Vienna, Austria
View Trial DetailsNCT03112486
Brain Anoxia Ischemia, Brain Diseases
Gainesville, Florida, United States
View Trial DetailsNCT01753024
Acute Kidney Injury, Acute Renal Failure
Shanghai, Shanghai Municipality, China
View Trial Details